Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.56 - $6.04 $359,560 - $610,040
-101,000 Reduced 46.63%
115,600 $595,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.9 $846,906 - $1.28 Million
216,600 New
216,600 $1.06 Million

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $26M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.